Volume 34 Number 16 April 23-30, 2015
Cancer
Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.
Crona DJ et al. Pharmacogenomics J. 2015 Apr 14.
Crona DJ et al. Pharmacogenomics J. 2015 Apr 14.
Commercially available prognostic molecular models in early-stage lung cancer: a review of the Pervenio Lung RS and Myriad myPlan Lung Cancer tests.
Zheng Y et al. Expert Rev. Mol. Diagn. 2015 May 15(5) 589-96
Zheng Y et al. Expert Rev. Mol. Diagn. 2015 May 15(5) 589-96
Cost effectiveness of using array-CGH for diagnosing learning disability.
Sagoo GS et al. Appl Health Econ Health Policy 2015 Apr 19.
Sagoo GS et al. Appl Health Econ Health Policy 2015 Apr 19.
Family history and risk of pregnancy-associated breast cancer (PABC).
Johansson AL et al. Breast Cancer Res. Treat. 2015 Apr 19.
Johansson AL et al. Breast Cancer Res. Treat. 2015 Apr 19.
Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapy.
Lartigue L et al. Eur. J. Cancer 2015 Jan 51(1) 75-83
Lartigue L et al. Eur. J. Cancer 2015 Jan 51(1) 75-83
Interest in genomic SNP testing for prostate cancer risk: a pilot survey.
Hall MJ et al. Hered Cancer Clin Pract 2015 13(1) 11
Hall MJ et al. Hered Cancer Clin Pract 2015 13(1) 11
KRAS testing of patients with metastatic colorectal cancer in a community-based oncology setting: a retrospective database analysis.
Carter GC et al. J. Exp. Clin. Cancer Res. 2015 34(1) 29
Carter GC et al. J. Exp. Clin. Cancer Res. 2015 34(1) 29
Long-term cost-effectiveness of Oncotype DX(®) versus current clinical practice from a Dutch cost perspective.
Kip M et al. J Comp Eff Res 2015 Apr 15. 1-13
Kip M et al. J Comp Eff Res 2015 Apr 15. 1-13
Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S et al. Sci Transl Med 2015 Apr 15. 7(283) 283ra53
Jones S et al. Sci Transl Med 2015 Apr 15. 7(283) 283ra53
Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators.
Schneider JL et al. Genet. Med. 2015 Apr 16.
Schneider JL et al. Genet. Med. 2015 Apr 16.
Validation of an NGS approach for diagnostic BRCA1/BRCA2 mutation testing.
Dacheva D et al. Mol Diagn Ther 2015 Apr 17.
Dacheva D et al. Mol Diagn Ther 2015 Apr 17.
New genetic tests for breast cancer hold promise, by Andrew Pollack, New York Times, Apr 21
by Andrew Pollack, New York Times, Apr 21Assessing breast cancer risk: Beyond the Angelina Effect By Ricki Lewis, Genetic Literacy Project, Apr 16
By Ricki Lewis, Genetic Literacy Project, Apr 16
.png)
No hay comentarios:
Publicar un comentario